Periodate-induced lymphocyte transformation. V. Inhibition of periodate-induced transformation of human peripheral lymphocytes with aldehyde-blocking agents.
D001894:Borohydrides / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D003510:Cyclohexanes / Q000494:pharmacology*; D003512:Cyclohexanones / Q000494:pharmacology*; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology*; D006898:Hydroxylamines / Q000494:pharmacology*; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects*; D010504:Periodic Acid / Q000037:antagonists & inhibitors*; D010659:Phenylhydrazines / Q000494:pharmacology; D012663:Semicarbazides / Q000494:pharmacology; D013447:Sulfites / Q000494:pharmacology; D013871:Thiones / Q000494:pharmacology; D013882:Thiosemicarbazones / Q000494:pharmacology
D001894:Borohydrides; D003510:Cyclohexanes; D003512:Cyclohexanones; D006834:Hydrazines; D006898:Hydroxylamines; D037102:Lectins; D010659:Phenylhydrazines; D012663:Semicarbazides; D013447:Sulfites; D013871:Thiones; D013882:Thiosemicarbazones; D010504:Periodic Acid